One flagship workflow: the Regulatory Change Integrity Review.
Bring the exports and controlled records you already have. ClinicOps reconciles an approved change against every downstream regulated record that should reflect it — EUDAMED, UDI data, certificates, SS(C)P, declarations, labels, IFUs, controlled documents — and returns a source-linked exception queue with owners and closure evidence. No new platform to implement; your RIM, QMS, PLM and ERP stay exactly where they are.
The Regulatory Change Integrity Review
What goes in
One approved or authoritative regulatory/product change and a bounded downstream evidence population: the records, registers, documents and language versions your team expects to reflect it. A fixed evidence window and a named regulatory owner.
What comes out
A reviewer-ready closure packet: source register, change-surface matrix, deterministic comparison per surface, mismatch and missing-evidence findings, ownership routing for unresolved interpretation, and closure evidence. Core schema: Source · Expected · Observed · Status · Evidence · Owner · Next Action · Closure.
How it runs
Establish the authoritative source → identify declared downstream surfaces → normalize identifiers and versions → collect available evidence → compare deterministically → identify mismatches, missing evidence and ownership ambiguity → route unresolved interpretation to your qualified reviewers → produce the closure queue → capture closure evidence.
Why this shape
Regulatory teams already carry heavy administrative load across siloed systems. The review removes the deterministic comparison work without asking you to migrate anything — machines compare, your qualified team interprets and decides.
Most exceptions are documentary or data-related and close without clinical input. Where a bounded exception requires clinical context, ClinicOps can introduce appropriate independent specialist review — across medicine and nursing — as part of the evidence trail. How specialist review works →
Scope a change integrity review
Entering with a portfolio instead of a change
The same workflow can start from a defined device portfolio or regulatory export (CSV/XLSX/JSON, RIM or UDI exports, product master data, declared document registers, public EUDAMED evidence where available). The Portfolio Integrity Scan is that scope of the flagship review — not a separate product: a bounded evidence-reconciliation pass producing missing fields, conflicting values, missing evidence, record relationships and an owner/action queue, as a human-readable report plus a machine-readable export. It is the usual first engagement when no single change is on the table yet.
When changes keep coming
Continuous Portfolio Integrity Monitoring is the recurring extension of the same review — scheduled evidence checks, record-drift detection and a standing exception queue. It is deliberately activated only where a completed review demonstrates recurrence; ClinicOps does not sell monitoring infrastructure ahead of demonstrated need.
Where does your problem live?
EUDAMED and UDI data, SS(C)P operations, Class III / implantable MDR transition, authorised-representative portfolios, document control and Danish/multilingual version integrity are applications of this one workflow — each has its own page under use cases. Denmark-specific market access and Danish pharmacovigilance support are a separate secondary route on the Denmark page.